Although tumor-associated antigens on the surface of GC cells, including CEA, CA72-4 and CA50, can be used as indicators for early screening of GC, they are handicapped by high false positive and negative rates, low specificity and sensitivity. This evidence concerns the gene CEACAM5 and gastric cancer.